← Leaderboards
Michelle Van Name
Yale University
$2,822,271
Attributed
$2,822,271
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $725.3K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,822,271 · 2
By mechanism
R01$2,148,055 · 1
K23$674,216 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Gerald I Shulman$43,949,903
- Douglas Lyle Rothman$20,115,119
- Martin A. Schwartz$34,384,106
- Kitt F Petersen$7,646,269
- Raimund Ingo Herzog$9,466,184
Others in their field
Other Emerging Leaders on “Lipolysis”
- Joshua Wiley Knowles · Stanford University$6,163,002
- Pankaj Arora · University Of Alabama At Birmingham$5,870,690
- Gabi Hanna · Lamassu Pharma Inc.$3,317,651
- Emilio Mottillo · Wayne State University$3,282,702
- Vaia Lida Chatzi · University Of Southern California$3,229,657
- Elizabeth Rendina-Ruedy · Mainehealth$2,797,923
Research focus
LipolysisIsotopesGlycerolGlucose ProductionInsulinInsulin ResistanceCardiovascular SystemFatty Acid Glycerol EstersGlucoseGlucose ClampGlycosylated Hemoglobin AHepaticAdolescentInsulin-Dependent Diabetes MellitusAbdomenBody Weight DecreasedDiabetes MellitusComplications Of Diabetes MellitusFatty LiverFutureAdult ObesityCardiovascular Disorder RiskAffectMagnetic Resonance Imaging
Grant awards (7)
Obesity complicating type 1 diabetes in young people: Physiology and Impact of GLP-1 analogue anti-obesity treatment on cardiometabolic risk factors$725,290
R01 · FY2025 · DK · contact PI
Obesity complicating type 1 diabetes in young people: Physiology and Impact of GLP-1 analogue anti-obesity treatment on cardiometabolic risk factors$698,781
R01 · FY2024 · DK · contact PI
Obesity complicating type 1 diabetes in young people: Physiology and Impact of GLP-1 analogue anti-obesity treatment on cardiometabolic risk factors$723,984
R01 · FY2023 · DK · contact PI
Effect of adiposity on hepatic and peripheral insulin resistance and hepatic steatosis in pubertal adolescents with type 1 diabetes$87,896
K23 · FY2021 · DK · contact PI
Effect of adiposity on hepatic and peripheral insulin resistance and hepatic steatosis in pubertal adolescents with type 1 diabetes$194,940
K23 · FY2020 · DK · contact PI
Effect of adiposity on hepatic and peripheral insulin resistance and hepatic steatosis in pubertal adolescents with type 1 diabetes$194,940
K23 · FY2019 · DK · contact PI
Effect of adiposity on hepatic and peripheral insulin resistance and hepatic steatosis in pubertal adolescents with type 1 diabetes$196,440
K23 · FY2018 · DK · contact PI